Cuzzocrea et al. reported that a metastatic NPC patient had hypothyroidism and a concomitant rise in anti-thyroid peroxidase (A-TPO) antibody after treatment with nivolumab and chemoradiotherapy [17]. Here, TPO is linked to nasopharyngeal carcinoma.